CompletedPhase 1NCT01438073
Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling
Studying Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Stephanie B Seminara, MDMassachusetts General Hospital
- Intervention
- kisspeptin 112-121(drug)
- Enrollment
- 96 enrolled
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2011 – 2016
Study locations (1)
- Massachusetts General Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01438073 on ClinicalTrials.govOther trials for Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT05971836The Molecular Basis of Inherited Reproductive DisordersStephanie B. Seminara, MD
- ACTIVE NOT RECRUITINGNCT04733274Patient and Healthcare Professional Views on Genetic/Genomic Information and TestingBoston College
- RECRUITINGNCT01601171Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or PalateCentre Hospitalier Universitaire Vaudois